Abstract.
Aims:
To describe the frequency, timing and outcome from gastrostomy in amyotrophic lateral sclerosis/motor neurone disease (ALS/MND).
Methods:
The Scottish MND Register, a population based disease register (1989–1998), with record linkage to the Scottish Morbidity 1 dataset of hospital discharges coded for gastrostomy procedure was used. Descriptive statistics of patients undergoing gastrostomy were extracted. Survival analysis used Kaplan Meier and Cox proportional hazards methods.
Results:
For patients diagnosed between 1989–98, 142 percutaneous endoscopic gastrostomy (PEG) insertion episodes were identified in 1226 patients, 130 of which occurred before the censoring date of 31 December 1999.Annually, on average, 5% of all revalent patients underwent gastrostomy, and this rate appeared to double between 1989–98. The cumulative incidence of gastrostomy was 11%.Mean age at PEG tube insertion was 66.8 years, with a mean disease duration of 24 months. Median survival from PEG tube insertion was 146 days. The 1 month mortality after gastrostomy was 25%. Gastrostomy did not confer a survival advantage compared with no gastrostomy.
Conclusions:
We found that gastrostomy feeding tubes are being inserted more frequently in people with ALS/MND. An unexpectedly high early mortality was detected which probably reflects a lack of selection bias compared with previously published data. It is possible that changes in the practice of gastrostomy placement since 1998 result in better outcomes for patients with ALS/MND. Prospective studies are required to assess the risks and benefits of enteral nutrition in ALS/MND.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Anonymous (1992) The Scottish Motor Neurone Disease Register: a prospective study of adult onset motor neurone disease in Scotland.Methodology, demography and clinical features of incident cases in 1989. J Neurol Neurosurg Psychiatry 55:536–541
Bradley WG, Anderson F, Bromberg M, et al. (2001) Current Management of ALS: comparison of the ALSCARE database and the AAN Practice Parameter. Neurology 57:500–504
Brooks BR (1994) El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neurone Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial “Clinical limits of amyotrophic lateral sclerosis” workshop contributors. J Neurol Sci 124(Suppl):96–107
Caroscio JT, Mulvihill MN, Sterling R, Abrams B (1987) Amyotrophic lateral sclerosis. Its natural history. Neurol Clin 5(1):1–8
Chio A, Mora G, Leone M, Mazzini L, Cocito D, Giordana M, et al. (2002) Early symptom progression rate is related to ALS outcome. Neurology 59:99–103
Chio A, Finocchiaro E, Meineri P, Bottacchi E, Schiffer D (1999) Safety and factors related to survival after percutaneous endoscopic gastrostomy in ALS. ALS Percutaneous Endoscopic Gastrostomy Study Group. Neurology 53:1123–1125
Desport JC, Preux PM, Truong CT, Courat L, Vallat JM, Couratier P (2000) Nutritional assessment and survival in ALS patients. Amyotrophic Lateral Sclerosis & Other Motor Neurone Disorders 1:91–96
Gregory S, Siderowf A, Golaszewski AL, McCluskey L (2002) Gastrostomy insertion in ALS patients with low vital capacity: respiratory support and survival. Neurology 58:485–487
Hook E, Regal R (1992) The value of capture recapture methods even for apparent exhaustive surveys. Am J Epidemiol 135:1060–1067
Kasarskis EJ, Scarlata D, Hill R, Fuller C, Stambler N, Cedarbaum JM (1999) A retrospective study of percutaneous endoscopic gastrostomy in ALS patients during the BDNF and CNTF trials. J Neurol Sci 169:118–125
Kondo K, Hemmi I (1984) Clinical statistics in 515 fatal cases of motor neurone disease. Neuroepidemiology 3:129–148
Lee JR, Annegers JF, Appel SH (1995) Prognosis of amyotrophic lateral sclerosis and the effect of referral selection. J Neurol Sci 132(2):207–215
Mathus-Vliegen LM, Louwerse LS, Merkus MP, Tytgat GN, Vianney de Jong JM (1994) Percutaneous endoscopic gastrostomy in patients with amyotrophic lateral sclerosis and impaired pulmonary function. Gastrointest Endosc 40:463–469
Mazzini L, Corra T, Zaccala M, Mora G, Del Piano M, Galante M (1995) Percutaneous endoscopic gastrostomy and enteral nutrition in amyotrophic lateral sclerosis. J Neurol 242:695–698
Park R, Allison M, Lang J, et al. (1992) Randomised comparison of percutaneous endoscopic gastrostomy and nasogastric feeding in patients with persisting neurogenic dysphagia. BMJ 304:1406–1409
Scott AG, Austin HE (1994) Nasogastric feeding in the management of severe dysphagia in motor neuronedisease. Palliat Med 8:45–49
Strong MJ, Rowe A, Rankin RN (1999) Percutaneous gastrojejunostomy in amyotrophic lateral sclerosis. J Neurol Sci 169:128–132
Thornton FJ, Fotheringham T, Alexander M, Hardiman O, McGrath FP, Lee MJ (2002) Amyotrophic Lateral Sclerosis: Enteral Nutrition Provision—endoscopic or radiologic gastrostomy? Radiology 224:713–717
Author information
Authors and Affiliations
Consortia
Corresponding author
Rights and permissions
About this article
Cite this article
Forbes , R.B., Colville, S., Swingler, R.J. et al. Frequency, timing and outcome of gastrostomy tubes for amyotrophic lateral sclerosis/motor neurone disease. J Neurol 251, 813–817 (2004). https://doi.org/10.1007/s00415-004-0429-9
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s00415-004-0429-9